Health Care Delivery

Latest News


CME Content


CMS Administrator Seema Verma announced consumers buying health insurance through the exchanges set up by the Affordable Care Act (ACA) would be allowed to have heath savings accounts, and the agency will allow states to set their own subsidies and decide what type of health plan is eligible for subsidies. In addition, waivers would be evaluated against the Hyde amendment.

America's Health Insurance Plans (AHIP) released what it said are 12 proposals to help increase affordability for people who buy insurance on the individual market who do not qualify for subsidies. Meanwhile, CMS said 1.2 million people signed up for health insurance during the first 10 days of open enrollment for the individual marketplaces.

Project ECHO, which helps specialists disseminate knowledge to primary care providers, was created on the idea that patients should not be dying from curable diseases because they don’t have access to the right providers, said Sanjeev Arora, MD, FACG, MACP, director and founder of Project ECHO and a professor of medicine at University of New Mexico.

The midterm election is less than a month away, and a new poll tracking how Americans view healthcare issues finds that a majority of voters in 2 bellwether states—Nevada and Florida—prefer a candidate who supports keeping the Affordable Care Act (ACA)'s protections for people with pre-existing conditions.

CMS said Thursday that the average 2019 premium charged for the silver level of health insurance in the exchanges set up by the Affordable Care Act (ACA) dropped slightly for the first time since 2014, and Seema Verma, who heads CMS, credited the actions of the Trump administration for the lower premiums.

Senate Democrats were 1 vote short of overturning the Trump administration's expansion of short-term health plans; Celltrion’s CT-P10, a biosimilar to cancer drug Rituxan, received the unanimous support of an FDA advisory panel; Centene will enter 4 new states—North Carolina, Pennsylvania, South Carolina, and Tennessee—and expand offerings in 10 markets in 2019.

This week, the top managed care news included medical groups asking CMS to halt or slow down its plans to cut physician reimbursement for evaluation and management services; the Senate weighs a package of bills to combat the opioid epidemic; new research shows the Affordable Care Act pushed the uninsured rate down to 10%.

This week, the top managed care stories included a study on the impact physician burnout is having on care quality; the latest Affordable Care Act showdown took place in a Texas courtroom; the share of employers offering health coverage increased for the first time since 2008.

A hearing in a federal court in Fort Worth, Texas regarding the Affordable Care Act (ACA) ended Wednesday, with the attorney general for the Lone Star State leading 19 other like-minded Republican states in trying to convince a judge that a preliminary injunction to put the ACA on hold should be granted. Later, Senate Democrats tied the hearing to the Supreme Court nomination hearing for Judge Brett Kavanaugh, who, if confirmed, will likely have to consider the case, Texas v Azar.

The public, including most Republicans, wants protections for people with pre-existing conditions preserved, finds the latest Kaiser Family Foundation health tracking poll. The poll was released as a federal court case regarding the constitutionality of the Affordable Care Act got underway in Texas and as Brett Kavanaugh began his second day of questioning from senators regarding his nomination to the Supreme Court.

Senate Democrats plan to use the confirmation battle for Brett Kavanaugh's to the Supreme Court of the United States to mobilize their base around threats to the Affordable Care Act (ACA), the social safety net, and reproductive rights; a Texas courtroom will be the setting for another critical chapter in the fate of the ACA; consumers who buy insurance through ACA markets will find premiums have stabilized in 2019.

Brand Logo

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo